home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops  
 

An Overview of Process Validation for the Pharmaceutical, Medical Device and Related Industries

 
  February 02, 2009  
     
 
The Center for Professional Advancement, 90 Minute Accredited Online Training
March 26, 2009 at 11:00 a.m. - 12:30 p.m. (EST)


Who Should Attend
This online training course is intended for managers, supervisors, engineers, chemists, scientists, technicians and formulators working within the Pharmaceutical, Medical Device and related industries. It will also be valuable to documentation specialists, auditors and those in regulatory affairs. Personnel from the following departments will find the course beneficial:

  • Research and Development 
  • Manufacturing/Operations
  • Finance 
  • QA/QC
  • Quality Assurance and Control
  • Facilities
  • IT

This training will also benefit suppliers of equipment and services to these industries

Description
In recent years, the FDA has placed intense focus on Process Validation. This 90-minute accredited training course will examine will examine how we have reached the present validation environment and will give you a means for survival. It will provide a step-by-step guide to planning and preparing for process validation, and includes a discussion of how to write validation protocols, handle deviations, report validation results and “maintain the validated state.” The course provides a guide on how to manage the validation process efficiently and pragmatically. Further, this course provides “content understanding” so important for auditing validation activities as required in today's FDA regulated industry environment.

Module 1:
  • How did we reach the present validation environment?
  • Why do I need to validate processes?
  • What is process validation?
  • Does every process need to be validated?

Module 2:
  • The Validation Master Plan
  • Basics of validation
  • URS, DQ, FAT, IQ, OQ, PQ: What are all these letters in 
    the alphabet soup?
  • Protocol basics and content

Module 3:
  • Handling deviations
  • Validation reports
  • Proper validation timing
  • Maintaining the validated state
  • Auditing metrics for the validation system

Question and Answer Session

 
 
Organized by: The Center for Professional Advancement
Invited Speakers: William G. Marshall, President, William G. Marshall and Associates

William G. Marshall has over twenty years experience in the Pharmaceutical and Medical Device Manufacturing Environment. Mr. Marshall has held Director level and Chief Operating Officer positions with large multinational pharmaceutical corporations as well as start-up ventures. He has been the Director of a major reference laboratory, and has been active in clean room design and validation. In the last five years, he has acted as a third party in several consent decrees. Mr. Marshall is currently a consultant to the worldwide drug and device industry as well as to the FDA. He lectures worldwide in GMP related issues including Clean Room Technology and Sterilization. In the past 18 months, he has been involved in 10 Pre-Approval Inspections that include the first aseptic processed injectables from India, the first ever drugs from Turkey, and APIs from China, that were all approved for introduction to the US market. He has a Master's Degree in Biology from Georgetown University, Washington, DC. 
 
Deadline for Abstracts: n/a
 
Registration: Please click here for registration information.
E-mail: salbers@cfpa.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.